A 62-year-old man with congestive heart failure has been taking a loop diuretic to reduce peripheral edema. His labs reveal a serum potassium of 3.1 mEq/L, so a potassium-sparing diuretic, triamterene, is added to his regimen. Which of the following is the site of action of this agent?

Questions 263

ATI RN

ATI RN Test Bank

Lifespan Pharmacology Questions

Question 1 of 5

A 62-year-old man with congestive heart failure has been taking a loop diuretic to reduce peripheral edema. His labs reveal a serum potassium of 3.1 mEq/L, so a potassium-sparing diuretic, triamterene, is added to his regimen. Which of the following is the site of action of this agent?

Correct Answer: B

Rationale: In this scenario of a 62-year-old man with congestive heart failure and hypokalemia due to loop diuretic use, the addition of a potassium-sparing diuretic like triamterene is aimed at preventing further potassium loss. The correct answer is B) Collecting tubule. Triamterene acts on the collecting tubule by inhibiting the epithelial sodium channel (ENaC), thereby reducing sodium reabsorption and potassium secretion. This mechanism helps to retain potassium in the body, correcting hypokalemia. Option A) Ascending limb of loop of Henle is incorrect because loop diuretics like furosemide act here by inhibiting the Na+/K+/2Cl- cotransporter, leading to potassium loss. Option C) Descending limb of loop of Henle is also incorrect as loop diuretics act on the ascending limb, not the descending limb. Option D) Distal convoluted tubule is incorrect because thiazide diuretics act here by inhibiting the Na+/Cl- cotransporter, not potassium-sparing diuretics like triamterene. In an educational context, understanding the site of action of different diuretics is crucial for pharmacology students and healthcare professionals to make informed decisions when managing patients with fluid and electrolyte imbalances. Knowing the specific mechanisms of action of diuretics helps in prescribing the right medication for individual patient needs and avoiding potential adverse effects.

Question 2 of 5

A 42-year-old woman with irritable bowel syndrome with diarrhea predominance presents to her primary care physician for treatment. The physician suggests an exercise regimen, dietary modifications, and a bulk laxative. The likely mechanism of action of this agent would involve which of the following?

Correct Answer: A

Rationale: The correct answer is A) Gel formation in the intestine. In the case of irritable bowel syndrome with diarrhea, the use of a bulk laxative aims to increase stool bulk and consistency, thus reducing diarrhea. This is achieved through the mechanism of gel formation in the intestine by the bulk laxative. Option B) Neuromodulation of the S3 nerve root is incorrect as it pertains to a different mechanism of action not associated with bulk laxatives. Option C) Nonabsorbable salt is incorrect as it does not align with the mechanism of action of bulk laxatives. Option D) Osmotic laxative is incorrect as osmotic laxatives work by drawing water into the intestine to soften stool, which is different from the mechanism of action of a bulk laxative. In an educational context, understanding the mechanisms of action of different medications is crucial for healthcare providers to make informed decisions when treating patients. Knowing how medications work allows healthcare professionals to select the most appropriate treatment options based on a patient's condition and individual needs, ultimately leading to better patient outcomes.

Question 3 of 5

A 43-year-old woman with recurrent urinary tract infections who is usually sensitive to ciprofloxacin now has three consecutive UTIs in a 4-month period. Each time, the culture and sensitivity reveal resistance to ciprofloxacin. What is the most likely source of resistance?

Correct Answer: A

Rationale: In this scenario, the most likely source of resistance to ciprofloxacin in the 43-year-old woman with recurrent UTIs is option A) DNA gyrase. Ciprofloxacin is a fluoroquinolone antibiotic that targets bacterial DNA gyrase, an essential enzyme involved in DNA replication and repair. Resistance to ciprofloxacin often arises due to mutations in the DNA gyrase gene, leading to reduced drug binding and efficacy. Option B) DNA polymerase is involved in DNA synthesis, not the target of ciprofloxacin. Option C) DNA topoisomerase I and option D) DNA topoisomerase II are not the primary targets of ciprofloxacin. Understanding the mechanism of action of antibiotics like ciprofloxacin is crucial in determining the source of resistance and selecting appropriate treatment options. Educationally, this question highlights the importance of understanding the specific targets of antibiotics and how resistance can develop. It reinforces the need for clinicians to stay updated on antibiotic resistance patterns to make informed decisions when treating infections. Understanding the mechanisms of resistance can help in selecting alternative antibiotics or combination therapies to effectively manage recurrent infections.

Question 4 of 5

A 16-year-old boy with cystic fibrosis undergoes many types of treatments intended to loosen and thin the mucus obstructing his airways in order for him to expel it. He also takes an oral pancreatic enzyme because his pancreas is unable to secrete sufficient amounts because of mucus obstruction. Which of the following medications thins cystic fibrosis mucus by cleaving extracellular DNA?

Correct Answer: C

Rationale: In the case of the 16-year-old boy with cystic fibrosis, the correct answer is C) Dornase alfa. Dornase alfa is a medication that thins cystic fibrosis mucus by cleaving extracellular DNA, which helps to reduce the viscosity of the mucus, making it easier for the patient to expel. This drug specifically targets the thick, sticky mucus characteristic of cystic fibrosis. Acetylcysteine (Option A) is a mucolytic agent that works by breaking disulfide bonds within mucus, but it does not target extracellular DNA like Dornase alfa. Bromhexine (Option B) and Guaifenesin (Option D) are also mucolytic agents, but they do not specifically target DNA in the mucus as Dornase alfa does. In an educational context, it is important for healthcare professionals to understand the mechanisms of action of medications used in the treatment of cystic fibrosis to provide optimal care for patients. Knowing that Dornase alfa cleaves extracellular DNA to thin mucus can help in making informed decisions regarding treatment plans for individuals with cystic fibrosis.

Question 5 of 5

A 34-year-old construction worker injured his right leg while on the job. His medical history includes poorly controlled Type-2 diabetes mellitus. He now presents with cellulitis in his right leg, for which he is given empiric IV vancomycin. He also complains of nausea, for which he is given an antiemetic. Which of the following antiemetics is also an antihistamine?

Correct Answer: D

Rationale: In this scenario, the correct answer is D) Promethazine. Promethazine is both an antiemetic and an antihistamine. As an antiemetic, it helps to relieve nausea and vomiting. Its antihistamine properties make it effective in treating allergic reactions and symptoms like itching and hives. Option A) Droperidol is primarily an antiemetic that works by blocking dopamine receptors in the brain. It is not an antihistamine. Option B) Famotidine is a histamine-2 blocker used to reduce stomach acid production and treat conditions like acid reflux and ulcers. It is not an antiemetic or an antihistamine. Option C) Loratadine is a second-generation antihistamine used to treat allergies by blocking the action of histamine in the body. It is not an antiemetic. In an educational context, understanding the dual properties of medications like promethazine is crucial for healthcare professionals when managing patient symptoms effectively. Knowing the specific mechanisms of action of different classes of drugs helps in making informed decisions about their use, especially in complex cases like the one presented here with a diabetic patient with cellulitis and nausea.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions